Michael S. Brown - 23 Feb 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role: Director
Signature: /s/**Michael S. Brown
Issuer symbol: REGN
Transactions as of: 23 Feb 2022
Net transactions value: -$304,340
Form type: 4
Filing time: 24 Feb 2022, 15:07:06 UTC
Previous filing: 05 Jan 2022
Next filing: 31 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	REGN	Common Stock	Sale	$304,340	-500	-6.5%	$608.68	7,162	23 Feb 2022	by Trust
holding	REGN	Common Stock						1,082	23 Feb 2022	Direct
holding	REGN	Common Stock						5,000	23 Feb 2022	by SLAT	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are held in a trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Content

These shares are held in a trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.